Flexbumin
NDC 0944-0495, Albumin Human, injection, solution, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 0944-0495
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- PLASMA DERIVATIVE
- Marketing category
- BLA
- Application
- BLA101452
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0944-0495 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALBUMIN HUMAN.05 g/mL
Pharmacologic classes
Human Serum Albumin [EPC]; Increased Intravascular Volume [PE]; Increased Oncotic Pressure [PE]; Osmotic Activity [MoA]; Serum Albumin [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0944-0495-05 | 00944049505 | 2 BAG in 1 CARTON (0944-0495-05) / 250 mL in 1 BAG (0944-0495-06) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0944-0495 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0944-0495 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0944-0495. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.